ABSTRACT
Background Neglected tropical diseases (NTDs) often affect the most impoverished people in society. Uganda continues to carry a heavy burden of leprosy and lymphatic filariasis (LF). Both NTDs cause disfigurement and disability, often impacting the participation and inclusion of the affected persons. Their exclusion largely arises from the stigmatizing nature of both conditions and the limited knowledge and information. This research project conducted in 2018 investigated the participation of people with disabilities due to leprosy, LF, and other causes to inform appropriate intervention.
Methods A mixed-method approach including quantitative and qualitative methods was applied. A variety of data collection methods such as Participation scale (v6.0), focus group discussions, observation, and semi-structured interviews were used to achieve comprehensive conclusions on the various aspects of participation and inclusion of people with disabilities arising from leprosy, LF, and due to other causes.
Results Many people with disabilities due to leprosy and LF realize that they are affected by the disease only when it has advanced and they have developed visible disabilities. This is largely attributed to a lack of knowledge and information about the two diseases. About 27% reported no participation restriction, 25% reported severe, and 17% extreme participation restriction. Among people with disabilities due to LF a higher percentage reported no restriction, while higher percentages of respondents with disabilities due to leprosy and other causes reported severe and extreme restrictions. Participation restriction is experienced more by the female population.
Conclusion Although there is a general lack of data on disability experienced by people affected by leprosy and LF, a significant percentage (42.1%) experienced participation restriction. Disability due to leprosy and other causes is more likely to cause participation restriction than disability attributed to LF. Adequate knowledge and information, accessibility, acceptability, and affordability of services are key enablers of participation while their lack hinders participation and inclusion.
Author Summary Disability is estimated at 15% of an average population (WHO 2011). Disability inclusion is prioritized on the development agenda. It is explicitly mentioned in six out of the 17 goals (UN 2015). Leprosy and lymphatic filariasis are neglected tropical diseases that disfigure and affected persons and cause disability however, not much is documented on their participation in community development.
This study was implemented in 2018 to establish the nature and level of participation as well as a foundation upon which stigmatized people such as those affected by Leprosy, LF and disabilities due to other can be assured of participation and inclusion in community development programs. This mixed method study was implemented in five districts of Northern Uganda. Documents review, a participation scale, focus group discussions and semi-structured interviews were used to collect data.
This study revealed that due to lack of knowledge and information, many realize that they have leprosy and lymphatic filariasis when they have developed visible disabilities. It also revealed that people affected by leprosy, LF and PWDs access and benefit from health care services but are excluded from most mainstream community development programs. However, people affected by leprosy, people with disabilities due to other causes and the female with lymphedema reported more participation restriction than male with lymphatic filariasis. The key determinants of participation in community development are attitude, distance, funds, knowledge and information.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research project was implemented with financial support from the Leprosy Research Initiative with grant number 706.18.46. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research proposal was assessed by Gulu University Research Ethics Committee before submission to the National Council of Science and Technology for approval (SS4994) and implementation.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data will be accessed from the Kyambogo University Institutional Repository
